Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Ezaki Glico Co., Ltd. ( (JP:2206) ).
Ezaki Glico has disclosed that it received a shareholder proposal from LONGCHAMP SICAV, represented by Dalton Investments, seeking to nominate two outside directors, authorize large-scale share buybacks, revise restricted stock compensation, and amend the articles of incorporation to reinforce management awareness of capital costs and share price. After review by its board and its majority-outside Nomination and Compensation Committee, Glico’s directors resolved to oppose the director nominations, arguing the current board already has appropriate skill balance and diversity to execute its long-term strategy and mid-term management plan.
The board also expressed concern that the proposing shareholder is prioritizing short-term share-price gains and a potential take-private transaction, including a management buyout structure involving a private equity fund and rollover investment, which Glico believes could create conflicts of interest with general shareholders. Citing past interactions and public comments by Dalton’s chief investment officer about aiming to take Glico private, the company warned that the proposal could steer it toward privatization on terms misaligned with its focus on medium- to long-term value creation and the common interests of all shareholders.
The most recent analyst rating on (JP:2206) stock is a Hold with a Yen6199.00 price target. To see the full list of analyst forecasts on Ezaki Glico Co., Ltd. stock, see the JP:2206 Stock Forecast page.
More about Ezaki Glico Co., Ltd.
Ezaki Glico Co., Ltd. is a Japanese food manufacturer best known for confectionery and snack products, and it operates globally with a focus on delivering “great taste and good health” through high-quality ingredients. Guided by its Purpose of promoting healthier days and wellbeing for life, the company is executing a mid-term management plan for FY2025–FY2027 that targets ROE of 6–8%, uses ROIC-based management by business, and flexibly balances growth investment with shareholder returns.
Average Trading Volume: 176,277
Technical Sentiment Signal: Buy
Current Market Cap: Yen379.4B
Find detailed analytics on 2206 stock on TipRanks’ Stock Analysis page.